Acelyrin Inc (SLRN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
CEO:
Shao-Lee Lin
Employees:
4149 LIBERTY CANYON RD., AGOURA HILLS, CA, 91301
805-871-4300

ACELYRIN is a late-stage clinical biopharma company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. Our principal executive offices are located at 4149 Liberty Canyon Road, Agoura Hills, California.

Data derived from most recent annual or quarterly report
Market Cap 653.456 Million Shares Outstanding97.24 Million Avg 30-day Volume 1.374 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.87
Price to Revenue0.0 Debt to Equity0.0 EBITDA0
Price to Book Value1.3452 Operating Margin0.0 Enterprise Value196.765 Million
Current Ratio11.885 EPS Growth0 Quick Ratio11.792
1 Yr BETA 0.5466 52-week High/Low 29.88 / 5.77 Profit Margin0.0
Operating Cash Flow Growth0.0 Free Cash Flow to Firm (FCFF) TTM 0 Free Cash Flow to Equity (FCFE) TTM
Altman Z-Score9.0813

View recent insider trading info

Acelyrin Inc YCharts
Yahoo! Finance finviz

Funds Holding SLRN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SLRN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MACHADO PATRICK

  • Director
 14,675 2023-10-04 2

LABRUCHERIE GIL M CHIEF FINANCIAL OFFICER

  • Officer
 47,013 2023-10-04 3

LIN SHAO-LEE CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 3,487,389 2023-10-04 3

PELOSO PAUL CHIEF MEDICAL OFFICER

  • Officer
 160,644 2023-10-04 3

KIM MINA CHIEF LEGAL & ADMIN. OFFICER

  • Officer
 119,676 2023-08-16 2

GLORIA MELANIE CHIEF OPERATING OFFICER

  • Officer
 140,584 2023-08-16 2

OYSTON RONALD CHIEF PEOPLE OFFICER

  • Officer
 141,358 2023-08-16 2

SEIDENBERG BETH C

  • Director
  • 10% Owner
 9,850,729 2023-05-09 1

COZADD BRUCE C

  • Director
 0 2023-05-09 1

WESTLAKE BIOPARTNERS FUND II, L.P.

WESTLAKE BIOPARTNERS GP II, LLC

HARPER SEAN E

  • 10% Owner
 9,790,729 2023-05-09 1

AYURMAYA CAPITAL MANAGEMENT COMPANY, LP

GOEL DAVID E.

  • Director
  • SEE REMARKSSEE REMARKS
 9,334,735 2023-05-09 1

SVORONOS DAWN

  • Director
 15,000 2023-05-09 1

DIER MARDI CFO AND CBO

  • Officer
 7,306 2023-05-09 1

GOSEBRUCH HENRY O

  • Director
 50,000 2023-05-09 1

BECKER DANIEL J.

  • Director
 3,000 2023-05-09 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LIN SHAO-LEE - Director - Officer CHIEF EXECUTIVE OFFICER see footnote

2023-10-06 17:55:39 -0400 2023-10-04 J 132,236 a 487,205 indirect -1.5889 1.1917 -11.6187 3.7736 12 -20.3575 25

LIN SHAO-LEE - Director - Officer CHIEF EXECUTIVE OFFICER see footnote

2023-10-06 17:55:39 -0400 2023-10-04 J 1,161,747 d 0 indirect -1.5889 1.1917 -11.6187 3.7736 12 -20.3575 25

PELOSO PAUL - Officer CHIEF MEDICAL OFFICER see footnote

2023-10-06 17:55:04 -0400 2023-10-04 J 39,133 a 39,133 indirect -1.5889 1.1917 -11.6187 3.7736 12 -20.3575 25

LABRUCHERIE GIL M - Officer CHIEF FINANCIAL OFFICER see footnote

2023-10-06 17:53:54 -0400 2023-10-04 J 40,763 a 40,763 indirect -1.5889 1.1917 -11.6187 3.7736 12 -20.3575 25

MACHADO PATRICK - Director see footnote

2023-10-06 17:56:09 -0400 2023-10-04 J 14,675 a 14,675 indirect -1.5889 1.1917 -11.6187 3.7736 12 -20.3575 25

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ACELYRIN INC SLRN 2023-12-01 16:45:03 UTC 4.9048 0.4152 800000
ACELYRIN INC SLRN 2023-12-01 16:15:04 UTC 4.9048 0.4152 800000
ACELYRIN INC SLRN 2023-12-01 15:45:03 UTC 4.9048 0.4152 800000
ACELYRIN INC SLRN 2023-12-01 15:15:05 UTC 4.9048 0.4152 800000
ACELYRIN INC SLRN 2023-12-01 14:45:03 UTC 4.8799 0.4401 800000
ACELYRIN INC SLRN 2023-12-01 14:15:04 UTC 4.8799 0.4401 800000
ACELYRIN INC SLRN 2023-12-01 13:45:04 UTC 5.0144 0.3056 800000
ACELYRIN INC SLRN 2023-12-01 13:15:04 UTC 5.0144 0.3056 800000
ACELYRIN INC SLRN 2023-12-01 12:45:04 UTC 5.0144 0.3056 750000
ACELYRIN INC SLRN 2023-11-30 22:15:04 UTC 5.0412 0.2788 90000
ACELYRIN INC SLRN 2023-11-30 21:45:04 UTC 5.0412 0.2788 90000
ACELYRIN INC SLRN 2023-11-30 21:15:05 UTC 5.0412 0.2788 85000
ACELYRIN INC SLRN 2023-11-30 20:45:05 UTC 5.0412 0.2788 90000
ACELYRIN INC SLRN 2023-11-30 20:16:16 UTC 5.0456 0.2744 90000
ACELYRIN INC SLRN 2023-11-30 19:45:03 UTC 5.0456 0.2744 90000
ACELYRIN INC SLRN 2023-11-30 19:15:04 UTC 5.0456 0.2744 90000
ACELYRIN INC SLRN 2023-11-30 18:45:04 UTC 5.0456 0.2744 90000
ACELYRIN INC SLRN 2023-11-30 18:15:04 UTC 5.0456 0.2744 90000
ACELYRIN INC SLRN 2023-11-30 17:45:04 UTC 4.9718 0.3482 90000
ACELYRIN INC SLRN 2023-11-30 17:15:04 UTC 4.9718 0.3482 90000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund SLRN -774.0 shares, $-19226.16 2023-07-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund SLRN -2800.0 shares, $-28476.0 2023-09-30 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments